Literature DB >> 16908549

3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.

J-h Kim1, K-H Chang, D G Na, I C Song, B J Kwon, M H Han, K Kim.   

Abstract

BACKGROUND AND
PURPOSE: Echo time (TE) can have a large influence on the spectra in proton MR spectroscopy ((1)H-MR spectroscopy). The purpose of this study was to comparatively assess the diagnostic value of 3T single-voxel (1)H-MR spectroscopy with short or intermediate TEs in grading cerebral gliomas.
METHODS: Single voxel (1)H-MR spectroscopy was performed at 3T in 35 patients with cerebral glioma. The spectra were obtained with both short (35 ms) and intermediate TEs (144 ms). Metabolite ratios of choline (Cho)/creatine (Cr), Cho/N-acetylaspartate (NAA), lipid and lactate (LL)/Cr and myo-inositol (mIns)/Cr were calculated and compared between short and intermediate TEs in each grade. After receiver operating characteristic curve analysis, diagnostic accuracy for each TE in differentiating high-grade glioma from low-grade glioma was compared.
RESULTS: At short TE, Cho/Cr and Cho/NAA ratios were significantly lower, and LL/Cr and mIns/Cr were significantly higher, compared with those at intermediate TE, regardless of tumor grade. Lactate inversion at intermediate TE was found in only 2 patients. At both TEs, there were significant differences in Cho/Cr and LL/Cr ratios between low- and high-grade gliomas. Diagnostic accuracy was slightly higher at short TE alone or combined with intermediate TE than intermediate TE alone (85.7% versus 82.9%).
CONCLUSION: Metabolite ratios were significantly different between short and intermediate TE. Cho/Cr and LL/Cr ratios at either TE were similarly useful in differentiating high-grade gliomas from low-grade gliomas. If only a single spectroscopic sequence can be acquired, short TE seems preferable because of poor lactate inversion at intermediate TE on 3T single-voxel (1)H-MR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908549      PMCID: PMC7977521     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  22 in total

1.  Single-voxel proton MRS of the human brain at 1.5T and 3.0T.

Authors:  P B Barker; D O Hearshen; M D Boska
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

2.  Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

Authors:  O Gonen; S Gruber; B S Li; V Mlynárik; E Moser
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

3.  The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.

Authors:  Filip Jírů; Monika Dezortová; Martin Burian; Milan Hájek
Journal:  MAGMA       Date:  2003-10-16       Impact factor: 2.310

4.  A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia.

Authors:  Ned Sacktor; Richard L Skolasky; Thomas Ernst; Xiangling Mao; Ola Selnes; Martin G Pomper; Linda Chang; Kai Zhong; Dikoma C Shungu; Karen Marder; Dean Shibata; Giovanni Schifitto; Linda Bobo; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2005-04       Impact factor: 4.813

5.  Lactate detection at 3T: compensating J coupling effects with BASING.

Authors:  D A Kelley; L L Wald; J M Star-Lack
Journal:  J Magn Reson Imaging       Date:  1999-05       Impact factor: 4.813

6.  Extraneous lipid contamination in single-volume proton MR spectroscopy: phantom and human studies.

Authors:  L Kwock; M A Brown; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  1997-08       Impact factor: 3.825

7.  Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction.

Authors:  Tomonori Isobe; Akira Matsumura; Izumi Anno; Takashi Yoshizawa; Yasushi Nagatomo; Yuji Itai; Tadao Nose
Journal:  Magn Reson Imaging       Date:  2002-05       Impact factor: 2.546

8.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Authors:  H Poptani; R K Gupta; R Roy; R Pandey; V K Jain; D K Chhabra
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

9.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

10.  Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.

Authors:  H Shimizu; T Kumabe; T Tominaga; T Kayama; K Hara; Y Ono; K Sato; N Arai; S Fujiwara; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  1996-04       Impact factor: 3.825

View more
  29 in total

1.  MR imaging characteristics of protoplasmic astrocytomas.

Authors:  Kevin L Tay; Alpha Tsui; Pramit M Phal; Katharine J Drummond; Brian M Tress
Journal:  Neuroradiology       Date:  2010-07-20       Impact factor: 2.804

2.  Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Domenico Catapano; Giuseppe M Giannatempo; Simona Bonavita; Maurizio Portaluri; Michela Tosetti; Vincenzo A d'Angelo; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

Review 3.  MRI evaluation and safety in the developing brain.

Authors:  Shannon Tocchio; Beth Kline-Fath; Emanuel Kanal; Vincent J Schmithorst; Ashok Panigrahy
Journal:  Semin Perinatol       Date:  2015-03-03       Impact factor: 3.300

Review 4.  The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.

Authors:  Qun Wang; Hui Zhang; JiaShu Zhang; Chen Wu; WeiJie Zhu; FangYe Li; XiaoLei Chen; BaiNan Xu
Journal:  Eur Radiol       Date:  2015-10-15       Impact factor: 5.315

5.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

6.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Authors:  Fumiyuki Yamasaki; Kaoru Kurisu; Yoshinori Kajiwara; Yosuke Watanabe; Takeshi Takayasu; Yuji Akiyama; Taiichi Saito; Ryosuke Hanaya; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

7.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

8.  Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.

Authors:  Eiji Matsusue; James R Fink; Jason K Rockhill; Toshihide Ogawa; Kenneth R Maravilla
Journal:  Neuroradiology       Date:  2009-10-16       Impact factor: 2.804

9.  Utility of multiparametric 3-T MRI for glioma characterization.

Authors:  Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley; Rishi Awasthi; Sulaiman Sheriff; Meng Gu; Nuzhat Husain; Sudipta Mohakud; Sanjay Behari; Chandra M Pandey; Ram K S Rathore; Daniel M Spielman; Jeffry R Alger
Journal:  Neuroradiology       Date:  2013-02-02       Impact factor: 2.804

10.  Role of advanced MR imaging modalities in diagnosing cerebral gliomas.

Authors:  T Scarabino; T Popolizio; F Trojsi; G Giannatempo; S Pollice; N Maggialetti; A Carriero; A Di Costanzo; G Tedeschi; U Salvolini
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.